Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hammerness P et al. - Treatment with relatively high doses of OROS MPH was associated with small but statistically significant mean increases in BP and HR, primarily during the first 6 weeks of treatment, without clinically meaningful changes in ECG. These observations are consistent with previous reports using lower doses.

Related Articles

Parenting Style as a Predictor of Adolescent Weight and Weight-Related Behaviors
Journal of Adolescent Health, 10/20/09    Relevance Score: 95%

The role of parent–adolescent attachment in the glycemic control of adolescents with type 1 diabetes: A pilot study
Families, Systems & Health, 10/12/09    Relevance Score: 94%

Adolescent beverage habits and changes in weight over time: findings from Project EAT
American Journal of Clinical Nutrition, 11/02/09    Relevance Score: 92%

Discrepant Trends in Mental Health Complaints Among Younger and Older Adolescents in Sweden
Journal of Adolescent Health, 10/07/09    Relevance Score: 92%

Parenting Characteristics in the Home Environment and Adolescent Overweight: A Latent Class Analysis
Obesity, 10/14/09    Relevance Score: 91%

Today in Neuro/Psych pharmacology...keeping you current

Modafinil for multiple sclerosis fatigue: Does it work
Clinical Neurology and Neurosurgery, 12/18/09

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry in six countries
Current Medical Research and Opinion, 12/18/09

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
Phytotherapy Research, 12/18/09